Drugs / Apocynin

Trials 6 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 15 trials
Phase 1 NCT03680404 Oct 2018 → Feb 2020 vascular disorder The University of Texas at Arlington Completed No outcome recorded
Phase 1 NCT03680573 Jan → May 2018 cardiovascular disorder The University of Texas at Arlington Completed No outcome recorded
Phase 1 NCT03680638 Sep 2016 → Oct 2017 cardiovascular disorder, isoproterenol-mediated vasodilatation The University of Texas at Arlington Completed No outcome recorded
Phase 1 NCT01402297 Oct 2010 → Jan 2011 chronic obstructive pulmonary disease Medical University of Lodz Completed No outcome recorded
Phase 1 NCT00992667 Jun → Aug 2008 asthma Medical University of Lodz Completed No outcome recorded
Phase 21 trial
Phase 2 NCT04657926 Sep 2020 → Sep 2021 osteoarthritis, knee AKL Research and Development Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 8 sources stand behind the page.

FieldValueCited text
Known as Apocynin ClinicalTrials.gov intervention name — accepted as the source's own label NCT03680638
4

NCT03680573

NCT03680404

NCT01402297

NCT00992667

Known as 1-(4-Hydroxy-3-methoxyphenyl)ethanone “This site will only be infused with apocynin (1-(4-Hydroxy-3-methoxyphenyl)ethanone; 100µM) during the local heating stimulus.” NCT03680638
1

“This site will receive 100 µM apocynin (1-(4-Hydroxy-3-methoxyphenyl)ethanone) at an infusion rate of 2 µl/min.” NCT03680573

Known as 4-hydroxy-3-methoxyacetophenone 4-hydroxy-3-methoxyacetophenone (4H3MA)” NCT04657926
Known as 4H3MA “4-hydroxy-3-methoxyacetophenone (4H3MA)” NCT04657926
Known as Acetovanillone ChEMBL registry synonym — accepted as the source's own label CHEMBL346919
Known as NSC-209524 ChEMBL registry synonym — accepted as the source's own label CHEMBL346919
Action Inhibit “Apocynin is an inhibitor of NADPH oxidase present in inflammatory cells such as eosinophils and neutrophils.” PMID 11728816 Dec 2001
Modality Small molecule CHEMBL346919
Route Inhaled “The aim of the study is to investigate the effect of inhaled apocynin on ROS (reactive oxygen species) and NOS (reactive nitrogen species) synthesis in 10 nonsmoking mild asthmatics.” NCT00992667